Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. (2014)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00125-014-3278-9
PubMed Identifier: 24893865
Publication URI: http://europepmc.org/abstract/MED/24893865
Type: Journal Article/Review
Volume: 57
Parent Publication: Diabetologia
Issue: 9
ISSN: 0012-186X